Replies

In November, the WHO issued a conditional recommendation against remdesivir because its review of additional studies found no benefit:

Data reviewed by the panel included results from this trial, as well as 3 other randomized controlled trials. In all, data from over 7000 patients across the 4 trials were considered.
The evidence suggested no important effect on mortality, need for mechanical ventilation, time to clinical improvement, and other patient-important outcomes.

You can talk about remdesivir on television, Twitter, or YouTube, and you will not be censored. The drug is still in use with a hefty price tag and requires hospitalization. However, if you talk about ivermectin, it appears you will be. Jonathan Turley, a law professor at Georgetown University, noted the following on his blog:

YouTube removed two videos from a December 8th hearing before the Committee on Homeland Security and Governmental Affairs. It featured Kory who discussed the use of Ivermectin as a potential treatment for Covid-19, particularly in the early stages. It is a drug that treats tropical diseases caused by parasites. Kory was calling for a review by the National Institutes of Health on trials for the drug. Ultimately, it does appear that the NIH did change the status of the drug.
Sen. Ron Johnson (R-WI) has said that the videos were blocked on his account, including Kory’s testimony. The Federalist maintained that YouTube removed the videos to the platform’s COVID-19 Medical Misinformation Policy. That policy stipulates that anything which goes against “local health authorities’ or the World Health Organization’s (WHO) medical information about COVID-19” will be removed.